NCT00068614View on ClinicalTrials.gov

HER-2 Protein Vaccine in Treating Women With Breast Cancer

PHASE1CompletedINTERVENTIONAL
Timeline

Start Date

July 31, 2003

Primary Completion Date

October 31, 2005

Conditions
Breast Cancer
Interventions
BIOLOGICAL

HER-2/neu peptide vaccine

Trial Locations (1)

44106-5055

Ireland Cancer Center, Cleveland

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Case Comprehensive Cancer Center

OTHER

NCT00068614 - HER-2 Protein Vaccine in Treating Women With Breast Cancer | Biotech Hunter | Biotech Hunter